-
Annual General Meeting
The activity Biochem Immunoassay India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
-
Balance Sheet
The activity Biochem Immunoassay India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
-
Director Appointment
Progress on Anand Kaushal was appointed as a Director was appointed as a Director on 16 Nov 2023 & has been associated with this company since 2 years 2 months . was documented.
-
Director Appointment
Shiv Kumar was appointed as a Director was appointed as a Director on 11 Dec 2014 & has been associated with this company since 11 years 1 month . was recorded as a recent event.
-
Company Incorporation
Progress on Biochem Immunoassay India Private Limited was registered on 11 Dec 2014 with Roc Delhi & aged 11 years 1 month as per MCA records. was documented.
Biochem Immunoassay India Private Limited, a active private limited company, was established on 11 December 2014 in New Delhi, Delhi, India. Engaging in preventive health services within the healthcare sector, it holds CIN: U24233DL2014PTC274034. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Shiv Kumar (Director), Anand Kaushal (Director). Past directors included Rajdev Choudhary, Ravindra Kashyap. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-24,G.F.,Na Paryavaran Complex,, New Delhi, Delhi, 110030.
Company Details
- CIN/LLPIN
U24233DL2014PTC274034
- Registration Number
274034
- Incorporation Date
11 December 2014
- Authorized Capital
₹0.10 M
- Paid-Up Capital
₹0.10 M
- ROC Code
Roc Delhi
-
Listing Status
Unlisted
- Company Status
Active
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 116.53%
- Profit Growth 125.95%
- Ebitda 129.11%
- Net Worth 35.23%
- Total Assets 72.90%
Biochem Immunoassay India Private Limited
Company Report FY 2025-2026Comprehensive Company Insights
Explore comprehensive insights into Biochem Immunoassay India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shiv Kumar | Director | 11 Dec 2014 | Current |
| Anand Kaushal | Director | 16 Nov 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 16 Nov 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biochem Immunoassay India Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 116.53% increase. The company also saw a substantial improvement in profitability, with a 125.95% increase in profit. The company's net worth Soared by an impressive increase of 35.23%.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
******* |
******* |
******* |
******* |
||
| Revenue from Operations |
|
******* |
******* |
******* |
******* |
||
| Total Assets |
|
******* |
******* |
******* |
******* |
||
| Profit or Loss |
|
*******
|
*******
|
*******
|
*******
|
||
| Net Worth |
|
*******
|
*******
|
*******
|
*******
|
||
| EBITDA |
|
******* |
******* |
******* |
******* |
In 2019, Biochem Immunoassay India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
-
Promoters: 92.83%
-
Public: 4.10%
-
Others: 3.07%
| FY (2024) | FY (2023) | FY (2022) | FY (2021) | FY (2020) | |
|---|---|---|---|---|---|
| Promoters | 92.83 | 94.62 | 94.55 | 94.55 | 94.55 |
| Public | 4.10 | 3.89 | 3.95 | 3.96 | 3.98 |
| Others | 3.07 | 1.49 | 1.50 | 1.49 | 1.47 |
Reveal ownership structures and financial performance - Get instant access now!
Unlock and access historical data on people associated with Biochem Immunoassay India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
| Employee Date | Number of Employees |
|---|---|
| 2020 | 78,000 |
| 2021 | 80,500 |
| 2022 | 83,200 |
| 2023 | 86,000 |
| 2024 | 89,500 |
| 2025 | 92,000 |
Gain comprehensive insights into the Deals and Valuation data of Biochem Immunoassay India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biochem Immunoassay India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
What is the CIN of Biochem Immunoassay India Private Limited?
The CIN of Biochem Immunoassay India Private Limited is U24233DL2014PTC274034.
Where is Biochem Immunoassay India Private Limited headquartered?
Biochem Immunoassay India Private Limited is headquartered at C-24,G.F.,Na Paryavaran Complex,, New Delhi, Delhi, 110030.
When was Biochem Immunoassay India Private Limited incorporated?
Biochem Immunoassay India Private Limited was incorporated on 11 December 2014.
Who are the current directors of Biochem Immunoassay India Private Limited?
The current directors of Biochem Immunoassay India Private Limited are
What is the primary industry of Biochem Immunoassay India Private Limited?
The primary industry of Biochem Immunoassay India Private Limited is Healthcare.
Is Biochem Immunoassay India Private Limited a listed company?
Biochem Immunoassay India Private Limited is unlisted.
What is the capital structure of Biochem Immunoassay India Private Limited?
The authorized capital of Biochem Immunoassay India Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
What is the compliance status of Biochem Immunoassay India Private Limited?
The compliance status of Biochem Immunoassay India Private Limited is Compliant.
+91-XXXXXXXXXX